Ameriprise Financial Inc Argenx Se Transaction History
Ameriprise Financial Inc
- $415 Billion
- Q3 2025
A detailed history of Ameriprise Financial Inc transactions in Argenx Se stock. As of the latest transaction made, Ameriprise Financial Inc holds 165,658 shares of ARGX stock, worth $150 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
165,658
Previous 111,195
48.98%
Holding current value
$150 Million
Previous $61.3 Million
99.34%
% of portfolio
0.03%
Previous 0.02%
Shares
25 transactions
Others Institutions Holding ARGX
# of Institutions
526Shares Held
26MCall Options Held
589KPut Options Held
320K-
Price T Rowe Associates Inc Baltimore, MD3.64MShares$3.31 Billion0.29% of portfolio
-
Janus Henderson Group PLC London, X02.58MShares$2.34 Billion0.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.19MShares$1.99 Billion2.46% of portfolio
-
Capital World Investors Los Angeles, CA1.96MShares$1.78 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY1.01MShares$918 Million0.01% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $50.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...